152 related articles for article (PubMed ID: 37182566)
1. Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis.
Stone CA; Garvey LH; Nasser S; Lever C; Triggiani M; Parente R; Phillips EJ
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2008-2022. PubMed ID: 37182566
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
[TBL] [Abstract][Full Text] [Related]
3. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunization Stress-Related Responses With COVID-19 mRNA Vaccine.
Imai K; Tanaka F; Kawano S; Esaki K; Arakawa J; Nishiyama T; Seno S; Hatanaka K; Sugiura T; Kodama Y; Yamada S; Iwamoto S; Takeshima S; Abe N; Kamae C; Aono S; Ito T; Yamamoto T; Mizuguchi Y
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2667-2676.e10. PubMed ID: 35953016
[TBL] [Abstract][Full Text] [Related]
5. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
6. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
[TBL] [Abstract][Full Text] [Related]
7. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
[TBL] [Abstract][Full Text] [Related]
9. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
[TBL] [Abstract][Full Text] [Related]
10. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
[TBL] [Abstract][Full Text] [Related]
11. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
[TBL] [Abstract][Full Text] [Related]
12. Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders.
Marković I; Božan M; Perković T; Paušek K; Nedeljković V; Perković M; Kelava T; Artuković M; Stipić Marković A
Medicine (Baltimore); 2022 Jul; 101(30):e29571. PubMed ID: 35905225
[TBL] [Abstract][Full Text] [Related]
13. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.
Khalid MB; Frischmeyer-Guerrerio PA
J Allergy Clin Immunol Glob; 2023 Feb; 2(1):1-13. PubMed ID: 36532656
[TBL] [Abstract][Full Text] [Related]
14. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 mRNA vaccine allergy.
Risma KA
Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
[TBL] [Abstract][Full Text] [Related]
16. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.
Carvalho JC; Cunha F; Coutinho IA; Loureiro C; Faria E; Bom AT
Acta Med Port; 2021 Jun; 34(7-8):541-547. PubMed ID: 34851819
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.
Corey KB; Koo G; Phillips EJ
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2254-2266. PubMed ID: 35550878
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
20. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.
Szebeni J; Storm G; Ljubimova JY; Castells M; Phillips EJ; Turjeman K; Barenholz Y; Crommelin DJA; Dobrovolskaia MA
Nat Nanotechnol; 2022 Apr; 17(4):337-346. PubMed ID: 35393599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
